Your shopping cart is currently empty

GNE-220 is a potent and selective inhibitor of MAP4K4, with an IC50 of 7 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,970 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,580 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,400 | 8-10 weeks | 8-10 weeks |
| Description | GNE-220 is a potent and selective inhibitor of MAP4K4, with an IC50 of 7 nM. |
| Targets&IC50 | MAP4K5:9 nM, MAP4K4:7 nM, MAP4K6:1.1 μM |
| In vitro | GNE-220 alters human umbilical vein endothelial cells (HUVEC) sprout morphology.?GNE-220 also reduces pERM+ retraction fibres in a dose-dependent manner.?GNE-220 also dose-dependently increased the number of active-INTβ1+ long focal adhesions (FAs).GNE-220 also inhibits a few other kinases with IC50s of 9 nM, 476 nM and 1.1 μM for MINK (MAP4K6), DMPK and KHS1 (MAP4K5), respectively. |
| Molecular Weight | 438.53 |
| Formula | C25H26N8 |
| Cas No. | 1199590-75-4 |
| Smiles | CC1=C2C(C=3C(N2)=NC=C(C3)C4=CC=C(C=C4)N5CCN(C)CC5)=NC(=N1)C6=CN(C)N=C6 |
| Relative Density. | 1.38 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.